Navigation Links
Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
Date:2/24/2009

PALO ALTO, Calif., Feb. 24 /PRNewswire/ -- Today, Genencor, a division of Danisco A/S, launched Accellerase(R) 1500, the next generation of its cellulosic ethanol enzyme product. Genencor introduced the product at the Renewable Fuels Association (RFA) 2009 National Ethanol Conference in San Antonio, TX.

Accellerase(R) 1500 is another significant step toward commercialization of biofuels and other biochemicals made from cellulosic feedstocks, such as agricultural residues and bioenergy crops. It also reinforces Genencor's position as a global leader in 2nd generation ethanol innovation.

"We're on course to fast-track commercialization of cellulosic ethanol," says Philippe Lavielle, Senior Vice President, Business Development, Genencor. "Accellerase was a breakthrough in the industry. Now, by launching this improved enzyme product, we reach another important technical milestone toward commercial-scale production of transportation fuel and other biochemicals from renewable, non-food feedstocks."

Accellerase(R) 1500 will lower one of the major cost hurdles to producing ethanol or biochemicals from cellulosic feedstocks, such as corn stover, sugarcane bagasse, wood chips, wheat straw, and switchgrass. In addition, Accellerase(R) 1500 has a significantly improved formulation and higher activity resulting in higher ethanol yields and robust operation in a wider variety of processes. The product is based on Genencor's patented gene expression technology and the division's 25-year history of biofuels research.

Accellerase(R) is critical to the hydrolysis step of converting biomass to ethanol or other biochemicals. In this step, plant material is broken down into sugars for fermentation to ethanol.

Genencor supplies Accellerase(R) as part of its dual-strategy to drive forward the cellulosic ethanol industry, which includes its dedicated enzyme business, and its joint venture DuPon
'/>"/>

SOURCE Genencor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
2. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
3. Genencor Appoints New Executive Vice President - Technical Enzymes
4. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
5. EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
6. Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement
7. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
8. BioSpace.com Launches a New Season of Industry Career Fairs
9. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
10. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... a leading North American IT solutions and managed services provider, ... Cisco® Partner Summit Country awards. Cisco named ... of the Year for Canada during ... Montreal . "We are thrilled ... this year,s conference," said David MacDonald , Softchoice,s President ...
(Date:5/1/2015)... , May 1, 2015 Albany Molecular ... William S. Marth , AMRI,s President and Chief ... Merrill Lynch 2015 Health Care Conference on Wednesday, May ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:4/30/2015)... Blythewood, South Carolina (PRWEB) May 01, 2015 ... steam system services, is extremely proud to announce that ... have been named as a winner of a Queen’s ... business success for the design and manufacture of a ... is the revolutionary alternative to traditional steam flow ...
(Date:4/30/2015)... South San Francisco, CA (PRWEB) April 30, 2015 ... revenues for the first quarter of 2015 were $4.4 million, ... The net loss for the first quarter was $8.9 ... compared to a net loss for the same period in ... diluted share. As of March 31, 2015, cash, cash equivalents ...
Breaking Biology Technology:Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8
... Therapeutics, Inc. today presented final results from its Phase ... of exenatide) for the treatment of type 2 diabetes ... the Study of Diabetes in Vienna, Austria. Results of ... (FPG) within 24 hours of the start of treatment ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... a conference call and webcast on Wednesday, October 28, at ... , , U.S. / Canada Dial-in Number: ... Participant Code: 51404008, Replay ...
... 30 InteKrin Therapeutics Inc. announced today positive results for ... 45th European Association for the Study of Diabetes ... will be presented at 1:45 PM Friday, October 2, 2009 ... His presentation is entitled "Impact of INT131 Besylate, a Selective ...
Cached Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 2Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 3Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 4Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 5BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET 2InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting 2
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/8/2015)...  Infinisource, a leading provider of SaaS-based Human Capital ... leading supplier of biometric identification and security solutions, ... advanced biometrically-enabled time clock, the companies announced today. ... setting a bold, new standard for the collection ... and mid-size employer. When connected to the iSolved ...
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... with a degree in chemical engineering, was recently elected ... the National Academy of Engineering is among the highest ... honors those who have made outstanding contributions to "engineering ... Space and Missile Systems Center, Air Force Space Command, ...
... Problems related to urination, including incontinence and having to get ... of discussion over recent years. New treatment options have also ... no study has effectively compared the bother of each of ... The FINNO Study is an ongoing questionnaire survey ...
... Ocean to get to the Sargasso Sea to spawn, they swim ... researchers from the University of Southern Denmark report: Even in deep ... is in decline, and all over the world biologists are struggling ... numbers back up. One of the great puzzles is why and ...
Cached Biology News:When you always gotta go… 2Threatened eels disappear in the deep on their way to the Sargasso Sea 2
... Lower operational costs. More efficient ... from limited sample volumes. Industry demands ... to using microbore chromatography for routine ... not adequately satisfy the need to ...
... in conjunction with your existing apoptosis protocols. Grow ... to your existing procedure (also reserve a non-induced ... you have induced apoptosis in your cells, add ... incubate the cells for an additional 15 minutes. ...
Kit Components: Anti-Acetylated Histone H3 Salmon Sperm DNA/Protein A Agarose All necessary buffers. ...
... The standard BioLogic LP system, ... chromatography applications without fraction collection. The ... BioLogic rack, accessory kit with MV-6 ... UV optics, conductivity cell, tubing and ...
Biology Products: